Health & Environmental Research Online (HERO)


Print Feedback Export to File
10173768 
Journal Article 
Supplemental Data 
Supplemental materials: Evaluation of developmental toxicity, developmental neurotoxicity, and tissue dose in zebrafish exposed to GenX and other PFAS 
Gaballah, S; Swank, A; Sobus, JR; Howey, XM; Schmid, J; Catron, T; Mccord, J; Hines, E; Strynar, M; Tal, T 
2020 
Yes 
Environmental Health Perspectives
ISSN: 0091-6765
EISSN: 1552-9924 
128 
English 
is a supplement to 6356901 Evaluation of developmental toxicity, developmental neurotoxicity, and tissue dose in zebrafish exposed to GenX and other PFAS
BACKGROUND: Per- and polyfluoroalkyl substances (PFAS) are a diverse class of industrial chemicals with widespread environmental occurrence. Exposure to long-chain PFAS is associated with developmental toxicity, prompting their replacement with short-chain and fluoroether compounds. There is growing public concern over the safety of replacement PFAS.

OBJECTIVE: We aimed to group PFAS based on shared toxicity phenotypes.

METHODS: Zebrafish were developmentally exposed to 4,8-dioxa-3H-perfluorononanoate (ADONA), perfluoro-2-propoxypropanoic acid (GenX Free Acid), perfluoro-3,6-dioxa-4-methyl-7-octene-1-sulfonic acid (PFESA1), perfluorohexanesulfonic acid (PFHxS), perfluorohexanoic acid (PFHxA), perfluoro-n-octanoic acid (PFOA), perfluorooctanesulfonic acid (PFOS), or 0.4% dimethyl sulfoxide (DMSO) daily from 0-5 d post fertilization (dpf). At 6 dpf, developmental toxicity and developmental neurotoxicity assays were performed, and targeted analytical chemistry was used to measure media and tissue doses. To test whether aliphatic sulfonic acid PFAS cause the same toxicity phenotypes, perfluorobutanesulfonic acid (PFBS; 4-carbon), perfluoropentanesulfonic acid (PFPeS; 5-carbon), PFHxS (6-carbon), perfluoroheptanesulfonic acid (PFHpS; 7-carbon), and PFOS (8-carbon) were evaluated.

RESULTS: PFHxS or PFOS exposure caused failed swim bladder inflation, abnormal ventroflexion of the tail, and hyperactivity at nonteratogenic concentrations. Exposure to PFHxA resulted in a unique hyperactivity signature. ADONA, PFESA1, or PFOA exposure resulted in detectable levels of parent compound in larval tissue but yielded negative toxicity results. GenX was unstable in DMSO, but stable and negative for toxicity when diluted in deionized water. Exposure to PFPeS, PFHxS, PFHpS, or PFOS resulted in a shared toxicity phenotype characterized by body axis and swim bladder defects and hyperactivity.

CONCLUSIONS: All emerging fluoroether PFAS tested were negative for evaluated outcomes. Two unique toxicity signatures were identified arising from structurally dissimilar PFAS. Among sulfonic acid aliphatic PFAS, chemical potencies were correlated with increasing carbon chain length for developmental neurotoxicity, but not developmental toxicity. This study identified relationships between chemical structures and in vivo phenotypes that may arise from shared mechanisms of PFAS toxicity. These data suggest that developmental neurotoxicity is an important end point to consider for this class of widely occurring environmental chemicals. https://doi.org/10.1289/EHP5843. 
Index Medicus 
PFAS
• Additional PFAS (formerly XAgency)
     Literature Search Update December 2021
          PubMed
          Web of Science
     4,8-Dioxa-3H-perfluorononanoic acid
     Ammonium 4,8-dioxa-3H-perfluorononanoate
     Perfluoropentanesulfonic acid
• Expanded PFAS SEM (formerly PFAS 430)
     Litsearch Update: November 2021
          Web of Science
     Perfluorooctane
• PFAS 150
     Literature Search Update December 2020
          PubMed
          WOS
     Literature Search August 2019
          PubMed
          Web of Science
     Screened Studies
          Supplemental
     Perfluorinated compounds
     Perfluoro-2-methyl-3-oxahexanoic acid
     Perfluorobutanesulfonyl fluoride
     Perfluoroheptanesulfonic acid
     Perfluorohexanesulfonic acid
     Perfluorohexanoic acid
     Perfluorooctane
     1,1,1,3,3,3-Hexafluoro-2- (fluoromethoxy)propane
• PFBS
     Search
          PubMed
     Lit Search Update: May 2019 - May 2020
          PubMed
     Lit Search Update: May 2020 - April 2021
          WOS
     Scopus: April 2021
• PFHxA
     LitSearch Update: May 2019 - May 2020
          PubMed
     LitSearch Update: May 2020 - April 2021
          WOS
     Scopus: April 2021
     HAWC
• PFHxS
     Database searches
          Pubmed
          WOS
          Scopus
     Excluded
          TiAb
• PFNA
     Literature Search
          Pubmed
          WOS
     LitSearch: May 2019 - May 2020
          PubMed
     LitSearch: May 2020 - April 2021
          WoS
• PFOA (335-67-1) and PFOS (1763-23-1)
     LitSearch: Feb 2019 - May 2020
          PubMed
     Literature Search Update (Apr 2019 - Sep 2020)
          PubMed
          WOS